Search Results - "Paolo, Antonello Di"
-
1
Pharmacokinetic drug-drug interaction and their implication in clinical management
Published in Journal of research in medical sciences (01-07-2013)“…Drug-drug interactions (DDIs) are one of the commonest causes of medication error in developed countries, particularly in the elderly due to poly-therapy, with…”
Get full text
Journal Article -
2
Oral Gentamicin Gut Decontamination for Prevention of KPC-Producing Klebsiella pneumoniae Infections: Relevance of Concomitant Systemic Antibiotic Therapy
Published in Antimicrobial agents and chemotherapy (01-04-2014)“…Gut colonization represents the main source for KPC-producing Klebsiella pneumoniae (KPC-Kp) epidemic dissemination. Oral gentamicin, 80 mg four times daily,…”
Get full text
Journal Article -
3
Pharmacogenetics of BCR/ABL Inhibitors in Chronic Myeloid Leukemia
Published in International journal of molecular sciences (21-09-2015)“…Chronic myeloid leukemia was the first haematological neoplasia that benefited from a targeted therapy with imatinib nearly 15 years ago. Since then, several…”
Get full text
Journal Article -
4
5-Fluorouracil Pharmacokinetics Predicts Disease-free Survival in Patients Administered Adjuvant Chemotherapy for Colorectal Cancer
Published in Clinical cancer research (01-05-2008)“…Purpose: To evaluate 5-fluorouracil (5-FU) and 5-fluoro-5,6-dihydrouracil (5-FDHU) pharmacokinetics and disease-free survival (DFS) in colorectal cancer…”
Get full text
Journal Article -
5
The pharmacological bases of the antiangiogenic activity of paclitaxel
Published in Angiogenesis (London) (01-07-2013)“…In the mid 1990s, researchers began to investigate the antiangiogenic activity of paclitaxel as a possible additional mechanism contributing to its…”
Get full text
Journal Article -
6
Personalized Medicine of Monoclonal Antibodies in Inflammatory Bowel Disease: Pharmacogenetics, Therapeutic Drug Monitoring, and Beyond
Published in Frontiers in pharmacology (08-02-2021)“…The pharmacotherapy of inflammatory bowel diseases (Crohn's disease and ulcerative colitis) has experienced significant progress with the advent of monoclonal…”
Get full text
Journal Article -
7
Personalized medicine in Europe: not yet personal enough?
Published in BMC health services research (19-04-2017)“…Personalized medicine has the potential to allow patients to receive drugs specific to their individual disease, and to increase the efficiency of the…”
Get full text
Journal Article -
8
Interactions between Food and Drugs, and Nutritional Status in Renal Patients: A Narrative Review
Published in Nutrients (04-01-2022)“…Drugs and food interact mutually: drugs may affect the nutritional status of the body, acting on senses, appetite, resting energy expenditure, and food intake;…”
Get full text
Journal Article -
9
The CoV-2 outbreak: how hematologists could help to fight Covid-19
Published in Pharmacological research (01-07-2020)“…[Display omitted] COVID-19 is a medical emergency, with 20 % of patients presenting with severe clinical manifestations. From the pathogenetic point of view,…”
Get full text
Journal Article -
10
Doxycycline, an Inhibitor of Mitochondrial Biogenesis, Effectively Reduces Cancer Stem Cells (CSCs) in Early Breast Cancer Patients: A Clinical Pilot Study
Published in Frontiers in oncology (12-10-2018)“…Cancer stem cells (CSCs) have been implicated in tumor initiation, recurrence, metastatic spread and poor survival in multiple tumor types, breast cancers…”
Get full text
Journal Article -
11
Concise Review: Chronic Myeloid Leukemia: Stem Cell Niche and Response to Pharmacologic Treatment
Published in Stem cells translational medicine (01-03-2018)“…Nowadays, more than 90% of patients affected by chronic myeloid leukemia (CML) survive with a good quality of life, thanks to the clinical efficacy of tyrosine…”
Get full text
Journal Article -
12
Concise Review: Resistance to Tyrosine Kinase Inhibitors in Non‐Small Cell Lung Cancer: The Role of Cancer Stem Cells
Published in Stem cells (Dayton, Ohio) (01-05-2018)“…Among the potential mechanisms involved in resistance to tyrosine kinase inhibitors (TKIs) in non‐small cell lung cancer, the manifestation of stem‐like…”
Get full text
Journal Article -
13
Pharmacogenetic Foundations of Therapeutic Efficacy and Adverse Events of Statins
Published in International journal of molecular sciences (06-01-2017)“…In the era of precision medicine, more attention is paid to the search for predictive markers of treatment efficacy and tolerability. Statins are one of the…”
Get full text
Journal Article -
14
Tyrosine Kinase Inhibitors Play an Antiviral Action in Patients Affected by Chronic Myeloid Leukemia: A Possible Model Supporting Their Use in the Fight Against SARS-CoV-2
Published in Frontiers in oncology (02-09-2020)“…SARS-CoV-2 is the viral agent responsible for the pandemic that in the first months of 2020 caused about 400,000 deaths. Among compounds proposed to fight the…”
Get full text
Journal Article -
15
Pharmacokinetics of Non-β-Lactam β-Lactamase Inhibitors
Published in Antibiotics (Basel) (24-06-2021)“…The growing emergence of drug-resistant bacterial strains is an issue to treat severe infections, and many efforts have identified new pharmacological agents…”
Get full text
Journal Article -
16
Association of plasma levetiracetam concentration, MGMT methylation and sex with survival of chemoradiotherapy-treated glioblastoma patients
Published in Pharmacological research (01-07-2022)“…Glioblastoma multiforme (GBM) is an aggressive brain tumor, often occurring with seizures managed with antiepileptic drugs, such as levetiracetam (LEV). This…”
Get full text
Journal Article -
17
Precision Medicine in Lymphoma by Innovative Instrumental Platforms
Published in Frontiers in oncology (17-12-2019)“…In recent years, many efforts have been addressed to the growing field of precision medicine in order to offer individual treatments to every patient on the…”
Get full text
Journal Article -
18
Tissue Penetration of Antimicrobials in Intensive Care Unit Patients: A Systematic Review—Part I
Published in Antibiotics (Basel) (29-08-2022)“…The challenging severity of some infections, especially in critically ill patients, makes the diffusion of antimicrobial drugs within tissues one of the…”
Get full text
Journal Article -
19
Appropriateness of repetitive therapeutic drug monitoring and laboratory turnaround time
Published in Clinical chemistry and laboratory medicine (26-11-2019)Get more information
Journal Article -
20
Population Pharmacokinetics of Intravenous Acyclovir in Oncologic Pediatric Patients
Published in Frontiers in pharmacology (14-04-2022)“…Acyclovir represents the first-line prophylaxis and therapy for herpes virus infections. However, its pharmacokinetics in children exposes them to the risk of…”
Get full text
Journal Article